The Neurotoxic Effects of Estrogen on Ischemic Stroke in Older Female Rats Is Associated with Age-Dependent Loss of Insulin-Like Growth Factor-1
Authors:
Open Access
- 19 May 2010
- journal article
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 30 (20) , 6852-6861
Abstract
Hormone therapy to postmenopausal females increases the risk and severity of ischemic stroke. Our previous work using an animal model of menopause (reproductive senescence) shows that middle cerebral artery occlusion (MCAo) causes a larger cortical–striatal infarct in this older acyclic group compared with younger females. Moreover, although estrogen treatment is neuroprotective in younger females, estrogen paradoxically increases infarct volume in acyclic females. We hypothesized that the neurotoxic effects of estrogen in older females occurs because of decreased availability of IGF-1, a neuroprotectant that decreases with advancing age and is downregulated by estrogen treatment. Our data show that plasma IGF-1 levels are significantly reduced in reproductive senescent females and further reduced by estrogen at all ages. The neuroprotective effect of estrogen on MCAo-induced cortical infarct volume in mature adult female is reversed by intracerebroventricular injections of IGF-1 receptor antagonist JB-1. Similarly, estrogens neurotoxic effects on cortical infarct volume in senescent females is attenuated by concurrent IGF-1 treatment, and reversed when IGF-1 is infused 4 h after the onset of ischemia (delayed IGF-1 treatment). Delayed IGF-1/estrogen treatment also suppressed ischemia-induced ERK1 phosphorylation, reduced protein oxidation, and stimulated an early increase in prostaglandin E2at the infarct site. IGF-1 treatment was only protective in senescent females that received estrogen, indicating that the neuroprotective actions of this peptide require interaction with the steroid hormone receptor. These data support the hypothesis that stroke severity in older females is associated with decreased IGF-1 and further indicate that short-term postischemic IGF-1 therapy may be beneficial for stroke.Keywords
This publication has 83 references indexed in Scilit:
- Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female ratsNeurobiology of Aging, 2010
- Homocysteine–NMDA receptor‐mediated activation of extracellular signal‐regulated kinase leads to neuronal cell deathJournal of Neurochemistry, 2009
- Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal ratsExperimental Neurology, 2009
- Changes in Experimental Stroke Outcome across the Life SpanJournal of Cerebral Blood Flow & Metabolism, 2009
- Insulin-like growth factor I promotes cord blood T cell maturation through monocytes and inhibits their apoptosis in part through interleukin-6BMC Immunology, 2008
- Stroke in Women: Risk and Prevention Throughout the LifespanNeurologic Clinics, 2008
- Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemiaNeuroscience Letters, 2008
- Distribution and localization patterns of estrogen receptor‐β and insulin‐like growth factor‐1 receptors in neurons and glial cells of the female rat substantia nigra: Localization of ERβ and IGF‐1R in substantia nigraJournal of Comparative Neurology, 2007
- Hormonal regulation of longevity in mammalsAgeing Research Reviews, 2007
- MAPK Signaling Is Critical to Estradiol Protection of CA1 Neurons in Global IschemiaEndocrinology, 2007